Company Filing History:
Years Active: 2001-2007
Title: Jerry McElroy: Innovator in Cancer Treatment
Introduction
Jerry McElroy is a notable inventor based in Richmond Hill, Canada. He has made significant contributions to the field of cancer treatment through his innovative methods and compositions. With a total of 4 patents to his name, McElroy continues to push the boundaries of medical science.
Latest Patents
One of McElroy's latest patents is a method and composition for inhibiting cancer cell growth. This invention provides improvements in treating cancer with weakly basic anti-cancer compounds. Specifically, it enhances the treatment of cancer cells in environments containing 1–8 mM urea by using a urease enzyme composition. This method reduces the amount of anti-cancer compound needed to achieve a desired level of growth inhibition. Another patent focuses on a pharmaceutical composition that includes a urease enzyme and a chemical entity to enhance the delivery of the enzyme to cancer cells. This composition aims to improve the effectiveness of weakly basic anti-tumor compounds and includes methods for assessing solid tumors and gene therapy compositions for cancer treatment.
Career Highlights
Jerry McElroy is currently associated with Helix Biopharma Corporation, where he applies his expertise in cancer research and treatment. His work has been instrumental in developing innovative solutions that address the challenges of cancer therapy.
Collaborations
McElroy collaborates with talented individuals in his field, including Heman Chao and Wah Yau Wong. These partnerships enhance the research and development efforts at Helix Biopharma Corporation.
Conclusion
Jerry McElroy's contributions to cancer treatment through his patents and collaborations highlight his commitment to advancing medical science. His innovative approaches continue to inspire progress in the fight against cancer.